AOD 9604 does not suppress appetite the way GLP-1 medications do
(Outlines contraindications for niacin therapy, including active peptic ulcer disease, active liver disease with elevated enzymes, hypersensitivity to niacin, and arterial bleeding, as well as monitoring recommendations for blood pressure, glucose, uric acid, etc., due to niacins systemic effects)
- 5-Amino-1MQ is studied in research models involving NNMT pathway activity, NAD+-adjacent metabolism, adipocyte biology, methylation-related signaling, cellular energy regulation, and body-composition pathway research
Purpose Lipotropic compounds are aminos used to aid in transporting fat and removing it from the body
AOD-9604 eliminates this confound entirely, allowing researchers to study fat metabolism pathway contributions in isolation